Business UpdateApr 30, 2026, 07:31 AM
HELP Interim CEO Eric So to Speak at Milken Institute Global Conference
AI Summary
Helus Pharma (CYBIN INC.) announced that its Interim Chief Executive Officer, Eric So, will speak at the 29th Annual Milken Institute Global Conference. He will participate in a panel discussion titled "The Next Wave of Health Innovation" on May 4, 2026. Helus Pharma is a clinical-stage pharmaceutical company focused on developing novel serotonergic agonists (NSAs) for mental health conditions, with lead candidates HLP003 in Phase 3 and HLP004 in Phase 2.
Key Highlights
- Helus Pharma Interim CEO Eric So to speak at 29th Annual Milken Institute Global Conference.
- Panel titled "The Next Wave of Health Innovation" on May 4, 2026, at 2:30 p.m. PDT.
- Conference takes place May 3-6, 2026, in Los Angeles.
- Helus Pharma is a clinical stage pharmaceutical company developing novel serotonergic agonists (NSAs).
- Company's lead candidate HLP003 is in Phase 3 for major depressive disorder with Breakthrough Therapy Designation.
- HLP004 is in Phase 2 for generalized anxiety disorder.
Price Impact
More from HELP